Voting results - Overview BioNTech SE, Mainz ordinary Annual General Meeting on 17/05/2024 Page 1Note: Percentages rounded to 2 decimal places Valid votes cast Yes votes No votes Shares % of capital stock Shares % Shares % Item 2 Resolution on the Appropriation of Balance Sheet Profit for the 2023 Financial Year 217,475,666 87.50 % 217,364,146 99.95 % 111,520 0.05 % Item 3 Resolution on the Approval of the Actions of the Management Board 177,450,928 71.39 % 177,279,149 99.90 % 171,779 0.10 % Item 4 Resolution on the Approval of the Actions of the Supervisory Board 214,986,400 86.50 % 212,475,898 98.83 % 2,510,502 1.17 % Item 5 Resolution on the Appointment of the Auditor of the Annual Financial Statements and the Auditor of the Consolidated Financial Statements for the 2024 Financial Year as well as the Auditor for any Audit or Review of Interim Financial Information During the Year 217,482,977 87.50 % 216,757,573 99.67 % 725,404 0.33 % Item 6 Resolution on the Approval of the Compensation Report 217,481,023 87.50 % 208,829,552 96.02 % 8,651,471 3.98 % Item 7 Resolution on the approval of the adjusted Compensation System for members of the Management Board 217,482,702 87.50 % 211,676,453 97.33 % 5,806,249 2.67 % Item 8 Resolution on the Adjustment of the Compensation System and the Compensation of the Supervisory Board members as well as the corresponding Amendment to Art. 9 para. 6 of the Articles of Association 217,478,894 87.50 % 212,415,111 97.67 % 5,063,783 2.33 % Item 9 Resolution on the Cancellation of an existing Authorization and the Creation of a new Authorization to issue Bonds with warrants and/or Convertible Bonds and to exclude Subscription Rights, together with the simultaneous Cancellation of the existing Conditional Capital WSV 2019 and the Creation of new Conditional Capital WSV 2024 as well as a corresponding Amendment to the Articles of Association 217,467,951 87.49 % 211,471,422 97.24 % 5,996,529 2.76 % Item 10 Resolution on the Authorization to acquire Treasury Shares, also excluding Tender Rights, and to use them, also excluding Subscription Rights, as well as the Cancellation of the existing Authorization 217,445,891 87.48 % 217,142,950 99.86 % 302,941 0.14 % Item 11 Resolution on the Authorization to use Derivatives in connection with the Acquisition of Treasury Shares 217,434,396 87.48 % 217,118,497 99.85 % 315,899 0.15 % Exhibit 99.3
Voting results - Overview BioNTech SE, Mainz ordinary Annual General Meeting on 17/05/2024 Page 2Note: Percentages rounded to 2 decimal places Valid votes cast Yes votes No votes Shares % of capital stock Shares % Shares % Item 12 Amendment of authorizations to issue Stock Options 217,482,638 87.50 % 217,152,276 99.85 % 330,362 0.15 % Item 13 Resolution on the partial Cancellation of the Conditional Capital ESOP 2017/2019, the partial Cancellation and Amendment of an Authorization to issue Stock Options (ESOP 2021) as well as on the partial Cancellation of the Conditional Capital ESOP 2021, a new authorization to issue Stock Options (ESOP 2024) and the Creation of a new Conditional Capital ESOP 2024 and corresponding Amendments to the Articles of Association 217,459,429 87.49 % 216,577,888 99.59 % 881,541 0.41 % Item 14 Resolution on the approval of the conclusion of a Domination and Profit and Loss Transfer Agreement between BioNTech SE and BioNTech Collaborations GmbH 217,467,268 87.49 % 217,415,742 99.98 % 51,526 0.02 %